CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Income Statement [Abstract]
Revenue	$ 0	$ 76,000	$ 3,000	$ 76,000
Cost of revenue	0	(13,000)	0	(13,000)
Gross profit	0	63,000	3,000	63,000
General and administrative expenses	470,000	346,000	715,000	564,000
Research and development expenses	4,000	16,000	11,000	24,000
Total operating expenses	474,000	362,000	726,000	588,000
Loss from operations	(474,000)	(299,000)	(723,000)	(525,000)
Other Income (expense)
Gain on patent assignment	0	880,000	0	880,000
Interest expense	(2,000)	(2,000)	(11,000)	(3,000)
Net income (loss)	$ (476,000)	$ 579,000	$ (734,000)	$ 352,000
Net income (loss) per share, Basic	$ (0.00)	$ 0.00	$ (0.00)	$ 0.00
Net income (loss) per share, Diluted	$ (0.00)	$ 0.00	$ (0.00)	$ 0.00
Weighted average shares outstanding, Basic	301,177,864	284,289,740	295,167,102	284,289,740
Weighted average shares outstanding, Diluted	301,177,864	284,289,740	295,167,102	284,289,740